{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T01:00:20Z","timestamp":1768179620779,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T00:00:00Z","timestamp":1472169600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["23797"],"award-info":[{"award-number":["23797"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s13277-016-5292-7","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T04:25:44Z","timestamp":1472185544000},"page":"14225-14234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Expression of the circulating and the tissue microRNAs after surgery, chemotherapy, and radiotherapy in mice mammary tumor"],"prefix":"10.1007","volume":"37","author":[{"given":"Sadaf","family":"Farsinejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Rahaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Mohammad","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Mir-Derikvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohre","family":"Gheisary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Nosrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solmaz","family":"Khalighfard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,26]]},"reference":[{"issue":"12","key":"5292_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893\u2013917.","journal-title":"Int J Cancer"},{"issue":"1","key":"5292_CR2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/bjs.7280","volume":"98","author":"S Fritz","year":"2011","unstructured":"Fritz S, Hackert T, Hinz U, Hartwig W, B\u00fcchler M, Werner J. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg. 2011;98(1):104\u201310.","journal-title":"Br J Surg"},{"issue":"6","key":"5292_CR3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"5292_CR4","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","volume":"26","author":"M Si","year":"2007","unstructured":"Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y. miR-21-mediated tumor growth. Oncogene. 2007;26(19):2799\u2013803.","journal-title":"Oncogene"},{"issue":"19","key":"5292_CR5","doi-asserted-by":"crossref","first-page":"14328","DOI":"10.1074\/jbc.M611393200","volume":"282","author":"S Zhu","year":"2007","unstructured":"Zhu S, Si M-L, Wu H, Mo Y-Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1. J Biol Chem. 2007;282(19):14328\u201336.","journal-title":"J Biol Chem"},{"issue":"29","key":"5292_CR6","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2005.05.5194","volume":"24","author":"C Roldo","year":"2006","unstructured":"Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol. 2006;24(29):4677\u201384.","journal-title":"J Clin Oncol"},{"issue":"2","key":"5292_CR7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1074\/jbc.M707224200","volume":"283","author":"LB Frankel","year":"2008","unstructured":"Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2008;283(2):1026\u201333.","journal-title":"J Biol Chem"},{"issue":"18","key":"5292_CR8","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.ejca.2008.09.037","volume":"44","author":"MV Iorio","year":"2008","unstructured":"Iorio MV, Casalini P, Tagliabue E, M\u00e9nard S, Croce CM. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer. 2008;44(18):2753\u20139.","journal-title":"Eur J Cancer"},{"issue":"4","key":"5292_CR9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1618","volume":"28","author":"L Ma","year":"2010","unstructured":"Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010;28(4):341\u20137.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"5292_CR10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1074\/jbc.M609383200","volume":"282","author":"GK Scott","year":"2007","unstructured":"Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem. 2007;282(2):1479\u201386.","journal-title":"J Biol Chem"},{"issue":"8","key":"5292_CR11","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-09-4250","volume":"70","author":"S Jiang","year":"2010","unstructured":"Jiang S, Zhang H-W, Lu M-H, He X-H, Li Y, Gu H, et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 2010;70(8):3119\u201327.","journal-title":"Cancer Res"},{"key":"5292_CR12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2016.02.090","volume":"151","author":"A Isanejad","year":"2016","unstructured":"Isanejad A, Alizadeh AM, Shalamzari SA, Khodayari H, Khodayari S, Khori V, et al. MicroRNA-206, let-7a and microRNA-21 pathways involved in the anti-angiogenesis effects of the interval exercise training and hormone therapy in breast cancer. Life Sci. 2016;151:30\u201340.","journal-title":"Life Sci"},{"issue":"16","key":"5292_CR13","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65(16):7065\u201370.","journal-title":"Cancer Res"},{"issue":"9","key":"5292_CR14","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.1007\/s13277-014-2421-z","volume":"35","author":"AM Alizadeh","year":"2014","unstructured":"Alizadeh AM, Shiri S, Farsinejad S. Metastasis review: from bench to bedside. Tumour Biol. 2014;35(9):8483\u2013523.","journal-title":"Tumour Biol"},{"issue":"1","key":"5292_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2199-9-34","volume":"9","author":"S Sharbati-Tehrani","year":"2008","unstructured":"Sharbati-Tehrani S, Kutz-Lohroff B, Bergbauer R, Scholven J, Einspanier R. miR-Q: a novel quantitative RT-PCR approach for the expression profiling of small RNA molecules such as miRNAs in a complex sample. BMC Mol Biol. 2008;9(1):1\u201313.","journal-title":"BMC Mol Biol"},{"issue":"30","key":"5292_CR16","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci. 2008;105(30):10513\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"5292_CR17","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.3390\/molecules19056282","volume":"19","author":"F Wang","year":"2014","unstructured":"Wang F, Hou J, Jin W, Li J, Yue Y, Jin H, et al. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis. Molecules. 2014;19(5):6282\u201393.","journal-title":"Molecules"},{"key":"5292_CR18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2015.03.076","volume":"758","author":"B Farhangi","year":"2015","unstructured":"Farhangi B, Alizadeh AM, Khodayari H, Khodayari S, Dehghan MJ, Khori V, et al. Protective effects of dendrosomal curcumin on an animal metastatic breast tumor. Eur J Pharmacol. 2015;758:188\u201396.","journal-title":"Eur J Pharmacol"},{"key":"5292_CR19","doi-asserted-by":"crossref","first-page":"824746","DOI":"10.1155\/2015\/824746","volume":"2015","author":"AM Alizadeh","year":"2015","unstructured":"Alizadeh AM, Sadeghizadeh M, Najafi F, Ardestani SK, Erfani-Moghadam V, Khaniki M, et al. Encapsulation of curcumin in diblock copolymer micelles for cancer therapy. BioMed research international. 2015;2015:824746.","journal-title":"BioMed research international"},{"issue":"1","key":"5292_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jmrs.1","volume":"60","author":"W Wang","year":"2013","unstructured":"Wang W. Radiotherapy in the management of early breast cancer. Journal of medical radiation sciences. 2013;60(1):40\u20136.","journal-title":"Journal of medical radiation sciences"},{"issue":"1","key":"5292_CR21","first-page":"52","volume":"33","author":"M Hemmati","year":"2011","unstructured":"Hemmati M, Abbaspour A, Alizadeh A, Khaniki M, Amanzadeh A, Mohagheghi M, et al. Rat xenograft chondrosarcoma development by human tissue fragment. Exp Oncol. 2011;33(1):52\u20134.","journal-title":"Exp Oncol"},{"issue":"1","key":"5292_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.09.015","volume":"718","author":"M Mohsenikia","year":"2013","unstructured":"Mohsenikia M, Alizadeh AM, Khodayari S, Khodayari H, Karimi A, Zamani M, et al. The protective and therapeutic effects of alpha-solanine on mice breast cancer. Eur J Pharmacol. 2013;718(1):1\u20139.","journal-title":"Eur J Pharmacol"},{"key":"5292_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2015.08.031","volume":"765","author":"V Khori","year":"2015","unstructured":"Khori V, Shalamzari SA, Isanejad A, Alizadeh AM, Alizadeh S, Khodayari S, et al. Effects of exercise training together with tamoxifen in reducing mammary tumor burden in mice: possible underlying pathway of miR-21. Eur J Pharmacol. 2015;765:179\u201387.","journal-title":"Eur J Pharmacol"},{"issue":"18","key":"5292_CR24","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","volume":"103","author":"S Costinean","year":"2006","unstructured":"Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, et al. Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E\u03bc-miR155 transgenic mice. Proc Natl Acad Sci. 2006;103(18):7024\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"5292_CR25","doi-asserted-by":"crossref","first-page":"e47003","DOI":"10.1371\/journal.pone.0047003","volume":"7","author":"Y Sun","year":"2012","unstructured":"Sun Y, Wang M, Lin G, Sun S, Li X, Qi J, et al. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One. 2012;7(10):e47003.","journal-title":"PLoS One"},{"issue":"4","key":"5292_CR26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","volume":"33","author":"RM O\u2019Connell","year":"2010","unstructured":"O\u2019Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010;33(4):607\u201319.","journal-title":"Immunity"},{"issue":"50","key":"5292_CR27","doi-asserted-by":"crossref","first-page":"43475","DOI":"10.1074\/jbc.M111.284158","volume":"286","author":"I Haque","year":"2011","unstructured":"Haque I, Banerjee S, Mehta S, De A, Majumder M, Mayo MS, et al. Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)\/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1\u03b1-TWIST signaling networks in human breast cancer cells. J Biol Chem. 2011;286(50):43475\u201385.","journal-title":"J Biol Chem"},{"issue":"7163","key":"5292_CR28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","volume":"449","author":"L Ma","year":"2007","unstructured":"Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449(7163):682\u20138.","journal-title":"Nature"},{"issue":"7","key":"5292_CR29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117(7):927\u201339.","journal-title":"Cell"},{"issue":"6","key":"5292_CR30","doi-asserted-by":"crossref","first-page":"E884","DOI":"10.1002\/ijc.27629","volume":"131","author":"SA Ibrahim","year":"2012","unstructured":"Ibrahim SA, Yip GW, Stock C, Pan JW, Neubauer C, Poeter M, et al. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism. Int J Cancer. 2012;131(6):E884\u201396.","journal-title":"Int J Cancer"},{"issue":"1","key":"5292_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-7-206","volume":"7","author":"N Anastasov","year":"2012","unstructured":"Anastasov N, H\u00f6fig I, Vasconcellos IG, Rappl K, Braselmann H, Ludyga N, et al. Radiation resistance due to high expression of miR-21 and G2\/M checkpoint arrest in breast cancer cells. Radiat Oncol. 2012;7(1):1.","journal-title":"Radiat Oncol"},{"issue":"3","key":"5292_CR32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jmb.2008.03.015","volume":"378","author":"S Fujita","year":"2008","unstructured":"Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K, et al. miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol. 2008;378(3):492\u2013504.","journal-title":"J Mol Biol"},{"issue":"11","key":"5292_CR33","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1261\/rna.1034808","volume":"14","author":"L-X Yan","year":"2008","unstructured":"Yan L-X, Huang X-F, Shao Q, Huang M-Y, Deng L, Wu Q-L, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14(11):2348\u201360.","journal-title":"RNA"},{"issue":"7","key":"5292_CR34","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"5292_CR35","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","volume":"27","author":"I Asangani","year":"2008","unstructured":"Asangani I, Rasheed S, Nikolova D, Leupold J, Colburn N, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008;27(15):2128\u201336.","journal-title":"Oncogene"},{"issue":"14","key":"5292_CR36","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","volume":"65","author":"JA Chan","year":"2005","unstructured":"Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029\u201333.","journal-title":"Cancer Res"},{"key":"5292_CR37","doi-asserted-by":"crossref","unstructured":"Hu HY, Li KP, Wang XJ, Liu Y, Lu ZG, Dong RH, et al. Set9, NF-\u03baB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. Acta Pharmacol Sin. 2013;34(1):157\u201366.","DOI":"10.1038\/aps.2012.161"},{"issue":"3","key":"5292_CR38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.onc.1207150","volume":"23","author":"N Hu","year":"2004","unstructured":"Hu N, Wang C, Han X-Y, He L-J, Tang Z-Z, Giffen C, et al. Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer. Oncogene. 2004;23(3):852\u20138.","journal-title":"Oncogene"},{"issue":"6","key":"5292_CR39","first-page":"743","volume":"25","author":"J Gao","year":"2013","unstructured":"Gao J, Zhang Q, Xu J, Guo L, Li X. Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. Chin J Cancer Res. 2013;25(6):743\u20138.","journal-title":"Chin J Cancer Res"},{"issue":"8","key":"5292_CR40","doi-asserted-by":"crossref","first-page":"e71472","DOI":"10.1371\/journal.pone.0071472","volume":"8","author":"D Zhao","year":"2013","unstructured":"Zhao D, Tu Y, Wan L, Bu L, Huang T, Sun X, et al. In vivo monitoring of angiogenesis inhibition via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer model using bioluminescent imaging. PLoS One. 2013;8(8):e71472.","journal-title":"PLoS One"},{"issue":"9","key":"5292_CR41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/dna.2009.0978","volume":"29","author":"MA Chaudhry","year":"2010","unstructured":"Chaudhry MA, Sachdeva H, Omaruddin RA. Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways. DNA Cell Biol. 2010;29(9):553\u201361.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"5292_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/cbr.2008.0513","volume":"24","author":"MA Chaudhry","year":"2009","unstructured":"Chaudhry MA. Real-time PCR analysis of micro-RNA expression in ionizing radiation-treated cells. Cancer Biother Radiopharm. 2009;24(1):49\u201356.","journal-title":"Cancer Biother Radiopharm"},{"key":"5292_CR43","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Becerra R, Santos N, Diaz L, Camacho J. Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, mirnas and genetically based resistance. Int J Mol Sci. 2013;14(1):108\u201345.","DOI":"10.3390\/ijms14010108"},{"issue":"12","key":"5292_CR44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jnci\/djt101","volume":"105","author":"Y Toiyama","year":"2013","unstructured":"Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst. 2013;105(12):849\u201359.","journal-title":"J Natl Cancer Inst"},{"key":"5292_CR45","doi-asserted-by":"crossref","unstructured":"Sun Y-M, Lin K-Y, Chen Y-Q. Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol. 2013;6(6).","DOI":"10.1186\/1756-8722-6-6"},{"issue":"6","key":"5292_CR46","doi-asserted-by":"crossref","first-page":"e40169","DOI":"10.1371\/journal.pone.0040169","volume":"7","author":"Q Bi","year":"2012","unstructured":"Bi Q, Tang S, Xia L, Du R, Fan R, Gao L, et al. Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One. 2012;7(6):e40169.","journal-title":"PLoS One"},{"key":"5292_CR47","doi-asserted-by":"crossref","unstructured":"Wagner-Ecker M, Schwager C, Wirkner U, Abdollahi A, Huber PE. MicroRNA expression after ionizing radiation in human endothelial cells. Radiation Oncology. 2010; 5(25).","DOI":"10.1186\/1748-717X-5-25"},{"issue":"1","key":"5292_CR48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.7314\/APJCP.2013.14.1.139","volume":"14","author":"B-S Zhao","year":"2013","unstructured":"Zhao B-S, Liu S-G, Wang T-Y, Ji Y-H, Qi B, Tao Y-P, et al. Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev. 2013;14(1):139\u201343.","journal-title":"Asian Pac J Cancer Prev"},{"key":"5292_CR49","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2014.04.023","volume":"735","author":"S Kardeh","year":"2014","unstructured":"Kardeh S, Ashkani-Esfahani S, Alizadeh AM. Paradoxical action of reactive oxygen species in creation and therapy of cancer. Eur J Pharmacol. 2014;735:150\u201368.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"5292_CR50","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s13277-015-3719-1","volume":"36","author":"S Farsinejad","year":"2015","unstructured":"Farsinejad S, Gheisary Z, Samani SE, Alizadeh AM. Mitochondrial targeted peptides for cancer therapy. Tumor Biol. 2015;36(8):5715\u201325.","journal-title":"Tumor Biol"},{"issue":"7","key":"5292_CR51","doi-asserted-by":"crossref","first-page":"e6377","DOI":"10.1371\/journal.pone.0006377","volume":"4","author":"NL Simone","year":"2009","unstructured":"Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, DeGraff W, et al. Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One. 2009;4(7):e6377.","journal-title":"PLoS One"},{"issue":"11","key":"5292_CR52","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/carcin\/bgs235","volume":"33","author":"L Zhao","year":"2012","unstructured":"Zhao L, Bode AM, Cao Y, Dong Z. Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis. 2012;33(11):2220\u20137.","journal-title":"Carcinogenesis"},{"issue":"6","key":"5292_CR53","doi-asserted-by":"crossref","first-page":"e67373","DOI":"10.1371\/journal.pone.0067373","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang L, Yuan C, Lv K, Xie S, Fu P, Liu X, et al. Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling. PLoS One. 2013;8(6):e67373.","journal-title":"PLoS One"},{"issue":"4","key":"5292_CR54","first-page":"e786","volume":"2","author":"G Marvaso","year":"2015","unstructured":"Marvaso G, Barone A, Amodio N. Emerging role of microRNAs in breast cancer radiotherapy. RNA & DISEASE. 2015;2(4):e786.","journal-title":"RNA & DISEASE"},{"issue":"4","key":"5292_CR55","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.3390\/molecules19045379","volume":"19","author":"F Cellini","year":"2014","unstructured":"Cellini F, Morganti AG, Genovesi D, Silvestris N, Valentini V. Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy. Molecules. 2014;19(4):5379\u2013401.","journal-title":"Molecules"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-5292-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-5292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:26:36Z","timestamp":1498325196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-5292-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,26]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["5292"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-5292-7","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,26]]}}}